Vilin Bio Med Limited

VILINBIO

INE0L4V01013

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 07:43:54 2024-06-13 am EDT			5-day change	1st Jan Change
19 ^INR	0.00%		-6.17%	-18.45%

May. 29	Vilin Bio Med Limited Announces Resignation of Padmaja Kalyani Sadhanala as Director	CI
May. 29	Vilin Bio Med Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI

Vilin Bio Med Limited Approves Resignation of Ashdeep Kaur from the Post of Company Secretary & Compliance Officer

February 24, 2024 at 01:50 am EST

Vilin Bio Med Limited at its board meeting held on February 24, 2024 has considered and approved the Resignation of Ms. Ashdeep Kaur from the post of Company Secretary & Compliance Officer. The Board has accepted her resignation and has relieved her from all responsibilities with effect from February 24, 2024.

Latest news about Vilin Bio Med Limited

Vilin Bio Med Limited Announces Resignation of Padmaja Kalyani Sadhanala as Director	May. 29	CI
Vilin Bio Med Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 29	CI
Vilin Bio Med Limited Announces Executive Changes	May. 04	CI
Vilin Bio Med Limited Approves Resignation of Ashdeep Kaur from the Post of Company Secretary & Compliance Officer	Feb. 24	CI
Vilin Bio Med Limited has completed an IPO in the amount of INR 120 million.	23-06-28	CI

Chart Vilin Bio Med Limited

Duration

Period

More charts

Company Profile

Vilin Bio Med Limited is an India-based company, which is engaged in the business of manufacturing and selling pharmaceutical products. The Company's primary products in manufacturing dosage forms include oral liquid (syrups/suspensions/dry powders) (beta & non-beta-lactam), tablets & capsules (beta & non-beta-lactam) and external preparations. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotics drugs, central nervous system drugs, alimentary system drugs, genitourinary tract drugs, respiratory system & anti-allergic drugs, anti-diabetic drugs, multi-vitamins, minerals & amino acids supplements, miscellaneous drugs, liquid orals and external preparations. Its cardiovascular drugs include ATORVOSTATIN + Aspirin Capsules, Dapagliflozin 10 milligrams (mg) TAB, Fluvastatin Tablets 40 mg, PRASUGREL 10 mg tablets, and Cilnidipine five mg tablets. Its external preparations include calamine lotion, and ciprofloxacin, fluocinolone acetonide and clotrimazole ointment.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VILIN BIO MED LIMITED	-18.45%	3.17M
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ASTRAZENECA PLC	+18.02%	246B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B